Neurocrine Biosciences shares owned by Westfield Capital Management Company
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Westfield Capital Management Company
from 13F filings
Historical chart of Westfield Capital Management Company investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Westfield Capital Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $67M | 485k | 137.67 |
| 2024-03-31 | $69M | 503k | 137.92 |
| 2023-12-31 | $78M | 594k | 131.76 |
| 2023-09-30 | $73M | 649k | 112.50 |
| 2023-06-30 | $35M | 375k | 94.30 |
| 2023-03-31 | $26M | 255k | 101.22 |
| 2022-12-31 | $33M | 273k | 119.44 |
| 2022-09-30 | $49M | 460k | 106.21 |
| 2022-06-30 | $52M | 529k | 97.48 |
| 2022-03-31 | $52M | 555k | 93.75 |
| 2021-12-31 | $60M | 706k | 85.17 |
| 2021-09-30 | $69M | 723k | 95.91 |
| 2021-06-30 | $60M | 615k | 97.32 |
| 2021-03-31 | $52M | 536k | 97.25 |
| 2020-12-31 | $45M | 464k | 95.85 |
| 2020-09-30 | $39M | 404k | 96.16 |
| 2020-06-30 | $49M | 400k | 122.00 |
| 2020-03-31 | $56M | 648k | 86.55 |
| 2019-03-31 | $28M | 317k | 88.10 |
| 2018-12-31 | $10M | 144k | 71.41 |
| 2018-06-30 | $18M | 185k | 98.24 |
| 2017-09-30 | $24M | 383k | 61.28 |
| 2017-06-30 | $64M | 1.4M | 46.00 |
| 2017-03-31 | $51M | 1.2M | 43.30 |
| 2016-12-31 | $54M | 1.4M | 38.70 |
| 2016-09-30 | $64M | 1.3M | 50.64 |
| 2016-06-30 | $58M | 1.3M | 45.45 |
| 2016-03-31 | $52M | 1.3M | 39.55 |
| 2015-12-31 | $69M | 1.2M | 56.57 |
| 2015-09-30 | $46M | 1.1M | 39.79 |
| 2015-06-30 | $56M | 1.2M | 47.76 |
| 2015-03-31 | $91M | 2.3M | 39.71 |
More positions owned by Westfield Capital Management Company
View all positions for Westfield Capital Management Company